Fitness cost of drug resistance mutations is relative and is modulated by other resistance mutations:: implications for persistance of transmitted resistance

被引：0
|
作者：
Cong, M [1 ]
Bennett, DE [1 ]
Heneine, W [1 ]
García-Lerma, JG [1 ]
机构：
[1] NCHSTP, Div HIV AIDS, CDC, Atlanta, GA USA
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
154
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [1] Fitness cost of drug resistance mutations is relative and is modulated by other resistance mutations:: implications for persistance of transmitted resistance
    Cong, M
    Bennett, DE
    Heneine, W
    García-Lerma, JG
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S169 - S169
  • [2] Fitness cost of chromosomal drug resistance-conferring mutations
    Sander, P
    Springer, B
    Prammananan, T
    Sturmfels, A
    Kappler, M
    Pletschette, M
    Böttger, EC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1204 - 1211
  • [3] The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance
    Hastings, IA
    Donnelly, MJ
    [J]. DRUG RESISTANCE UPDATES, 2005, 8 (1-2) : 43 - 50
  • [4] PRIMARY HIV-1 RESISTANCE - PERSISTENCE OF TRANSMITTED DRUG RESISTANCE MUTATIONS
    Nikolic, Valentina
    Salemovic, D.
    Jevtovic, D.
    Pesic-Pavlovic, I.
    Zerjav, S.
    Ranin, J.
    Siljic, M.
    Stanojevic, M.
    [J]. ARCHIVES OF BIOLOGICAL SCIENCES, 2012, 64 (04) : 1301 - 1309
  • [5] The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions
    Cong, Mian-er
    Heneine, Walid
    Garcia-Lerma, J. Gerardo
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (06) : 3037 - 3041
  • [6] Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis
    Emane, Amel Kevin Alame
    Guo, Xujun
    Takiff, Howard E.
    Liu, Shengyuan
    [J]. TUBERCULOSIS, 2021, 129
  • [7] Persistence of HIV-1 Transmitted Drug Resistance Mutations
    Castro, Hannah
    Pillay, Deenan
    Cane, Patricia
    Asboe, David
    Cambiano, Valentina
    Phillips, Andrew
    Dunn, David T.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1459 - 1463
  • [8] The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts
    Albacker, Lee A.
    Kohler, Rainer
    Weissleder, Ralph
    Sorger, Peter K.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21
  • [9] Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics
    Kuhnert, Denise
    Kouyos, Roger
    Shirreff, George
    Pecerska, Julija
    Scherrer, Alexandra U.
    Bonl, Jurg
    Yerly, Sabine
    Klimkait, Thomas
    Aubert, Vincent
    Gunthard, Huldrych F.
    Stadler, Tanja
    Bonhoeffer, Sebastian
    [J]. PLOS PATHOGENS, 2018, 14 (02)
  • [10] The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts
    Albacker, Lee A.
    Kohler, Rainer
    Weissleder, Ralph
    Sorger, Peter K.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21
12345